[
  {
    "ts": null,
    "headline": "Amgen (AMGN) Stock Moves 1.03%: What You Should Know",
    "summary": "In the most recent trading session, Amgen (AMGN) closed at $280.35, indicating a +1.03% shift from the previous trading day.",
    "url": "https://finnhub.io/api/news?id=eb2844f556485afbaf2f63b281154499bcc4a8a5c46b042c5001bdc83e293e9e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750888201,
      "headline": "Amgen (AMGN) Stock Moves 1.03%: What You Should Know",
      "id": 135553557,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "In the most recent trading session, Amgen (AMGN) closed at $280.35, indicating a +1.03% shift from the previous trading day.",
      "url": "https://finnhub.io/api/news?id=eb2844f556485afbaf2f63b281154499bcc4a8a5c46b042c5001bdc83e293e9e"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer on Keurig Dr Pepper: “I Don’t Want to Touch That One”",
    "summary": "Keurig Dr Pepper Inc. (NASDAQ:KDP) is one of the 12 stocks on Jim Cramer’s radar recently. A caller asked if the company would be able to compete with Coca-Cola long term despite its “high debt”. In response, Cramer said: “Yeah, no, I don’t want to touch that one. I think if you want to be […]",
    "url": "https://finnhub.io/api/news?id=1086952677b87adeaaacf1b52d97dcd2576d8617aa6124424f57a2f9334ab73a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750885164,
      "headline": "Jim Cramer on Keurig Dr Pepper: “I Don’t Want to Touch That One”",
      "id": 135531718,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Keurig Dr Pepper Inc. (NASDAQ:KDP) is one of the 12 stocks on Jim Cramer’s radar recently. A caller asked if the company would be able to compete with Coca-Cola long term despite its “high debt”. In response, Cramer said: “Yeah, no, I don’t want to touch that one. I think if you want to be […]",
      "url": "https://finnhub.io/api/news?id=1086952677b87adeaaacf1b52d97dcd2576d8617aa6124424f57a2f9334ab73a"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Inc. stock outperforms competitors on strong trading day",
    "summary": "Amgen Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=f504721038df06c4dc40da3d49aa0f7775662e8faeb2da0d226152fe29185445",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750869300,
      "headline": "Amgen Inc. stock outperforms competitors on strong trading day",
      "id": 135542162,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Amgen Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=f504721038df06c4dc40da3d49aa0f7775662e8faeb2da0d226152fe29185445"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why Amgen (AMGN) is a Strong Value Stock",
    "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
    "url": "https://finnhub.io/api/news?id=a7c0a803f2cdf7af8ef6453672a141767647170ce84fe84ad7e08b28cc7e4379",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750858801,
      "headline": "Here's Why Amgen (AMGN) is a Strong Value Stock",
      "id": 135527634,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
      "url": "https://finnhub.io/api/news?id=a7c0a803f2cdf7af8ef6453672a141767647170ce84fe84ad7e08b28cc7e4379"
    }
  },
  {
    "ts": null,
    "headline": "In the wake of Amgen Inc.'s (NASDAQ:AMGN) latest US$6.5b market cap drop, institutional owners may be forced to take severe actions",
    "summary": "Key Insights Given the large stake in the stock by institutions, Amgen's stock price might be vulnerable to their...",
    "url": "https://finnhub.io/api/news?id=806919b3cc5d70a6699053412c317f5fd73c4e71186bfc89086d8e717a183e0a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750856417,
      "headline": "In the wake of Amgen Inc.'s (NASDAQ:AMGN) latest US$6.5b market cap drop, institutional owners may be forced to take severe actions",
      "id": 135527635,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Key Insights Given the large stake in the stock by institutions, Amgen's stock price might be vulnerable to their...",
      "url": "https://finnhub.io/api/news?id=806919b3cc5d70a6699053412c317f5fd73c4e71186bfc89086d8e717a183e0a"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Stock May Be Worth Buying Again - Rating Upgrade",
    "summary": "Regeneron Pharmaceuticals Stock May Be Worth Buying Again - Rating Upgrade",
    "url": "https://finnhub.io/api/news?id=a3823b4eab8a3b599bb3f96eadd46ece5ce0a8a1b93cde82204d858cec42fb25",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750843166,
      "headline": "Regeneron Pharmaceuticals Stock May Be Worth Buying Again - Rating Upgrade",
      "id": 135525019,
      "image": "",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=a3823b4eab8a3b599bb3f96eadd46ece5ce0a8a1b93cde82204d858cec42fb25"
    }
  }
]